Complete Remission Rate， CRR

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Complete Remission Rate， CRR trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

Not Yet RecruitingNot Applicable

NCT07542912

Sintilimab, Chidamide, and Azacitidine for Untreated Stage I-II Extranodal NK/T-Cell Lymphoma

This is an open-label, single-arm, multi-center Phase II clinical trial evaluating the efficacy and safety of a novel sequential regimen as first-line therapy f…

China30 participantsStarted 2026-06-01

Treatment: SCA Induction followed by Response-Adapted Therapy